Correlation of Positron Emission Tomography and CT in Evaluating Pancreatic Tumors: Technical and Clinical Implications
Year: 2003
Type: review
Abstract: Principles and Instrumentation of PETPET permits radiolabeling with positron emitters (FDG) to create radiopharmaceutical agents that closely mimic endogenous molecules for evaluation of in vivo metabolic activity [12].Differential glucose metabolism in malignant and nonmalignant cell types forms the basis of using FDG, a glucose analogue for PET imaging.Studies have con-
Institutions: Harvard University, Massachusetts General Hospital
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W1973186057